Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: A pilot study

Table 5 Impact of PCA and ANA on sustained biochemical and virological response of the patients.

	Combined sustained response at the end of follow up [n (%)]
	n	Yes	No	P
PCA entry
Pos	9	0 (0)	9 (100)	0.022
Neg	48	19 (39.6)	29 (60.4)
ANA end of follow up
Pos	41	10 (24.4)	31 (75.6)	0.048
Neg	16	9 (56.3)	7 (43.7)

Abbreviations are same as in the text. n = the number of individuals in each group, P values were calculated by Fischer’s exact test or χ² where applicable.